13F-HR filed by Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 91 holding rows worth $958,704,189.
- Accession
- 0001420506-25-003321
- Filer
- CIK 1777015
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 91 entries on the cover page, a total value of $958,704,189 stated on the cover page (in dollars after the unit check, H1), rows summing to $958,704,189 with VALUE read as dollars as filed, 13F file number 028-19992. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVESCO QQQ TR | 46090E103 | COM | 80,000 | $48,029,600 | dollars as filed | put |
| Boston Scientific Corporation | 101137107 | COM | 434,377 | $42,408,227 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 87,690 | $39,986,640 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 116,238 | $35,886,158 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 379,486 | $28,609,450 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 671,592 | $26,077,917 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,154,487 | $24,913,829 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 251,420 | $24,764,870 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 64,108 | $23,698,804 | dollars as filed | |
| QIAGEN NV | N72482206 | COM SHS | 500,159 | $22,347,104 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 28,542 | $22,049,837 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 110,541 | $21,915,859 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,735,003 | $21,132,337 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 345,356 | $20,158,430 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 141,822 | $19,908,972 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 130,165 | $18,233,513 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 455,523 | $17,273,432 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 843,502 | $15,866,273 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 74,330 | $15,091,963 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 1,791,674 | $14,584,226 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 275,811 | $14,446,980 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 773,304 | $13,532,820 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,687,318 | $13,296,066 | dollars as filed | |
| DOXIMITY INC CL A | 26622P107 | Stock | 178,970 | $13,091,656 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 846,899 | $13,029,541 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 202,363 | $12,419,017 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 149,848 | $12,302,521 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 155,766 | $12,113,922 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 176,523 | $12,102,417 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 306,027 | $11,604,544 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 171,628 | $11,548,848 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 475,568 | $10,828,683 | dollars as filed | |
| OPTIMIZERX CORP | 68401U204 | COM NEW | 509,611 | $10,447,026 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 120,190 | $10,394,031 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 696,980 | $10,134,089 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 221,044 | $9,359,003 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 22,000 | $9,222,620 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 501,832 | $8,952,683 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 550,173 | $8,923,806 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 652,680 | $8,876,448 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 100,442 | $8,518,486 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 339,764 | $8,120,360 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 402,595 | $8,031,770 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 40,343 | $8,020,592 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 579,174 | $7,870,975 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,012,664 | $7,686,120 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 223,065 | $7,657,821 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 10,000 | $7,630,000 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 252,817 | $7,445,461 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 176,137 | $7,071,901 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 934,760 | $7,020,048 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 2,101,715 | $6,914,642 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 340,187 | $6,824,151 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 125,949 | $6,821,398 | dollars as filed | |
| CERTARA INC COM | 15687V109 | Stock | 551,850 | $6,743,607 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 250,981 | $6,425,114 | dollars as filed | |
| OUTSET MED INC | 690145206 | COM NEW | 454,512 | $6,417,709 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,440,633 | $5,881,926 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 250,000 | $5,875,000 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 30,000 | $5,698,200 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 847,675 | $5,687,899 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 378,583 | $5,572,742 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 200,000 | $5,186,000 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 45,250 | $4,875,235 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 55,197 | $4,686,225 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 105,831 | $4,204,666 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 351,131 | $4,111,744 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 61,849 | $4,108,629 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 100,380 | $4,029,253 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 491,408 | $3,965,663 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 656,084 | $3,523,171 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 380,713 | $3,422,610 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 200,753 | $3,364,620 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 73,725 | $3,070,646 | dollars as filed | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 913,443 | $3,050,900 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 96,737 | $2,811,177 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 271,306 | $2,694,069 | dollars as filed | |
| TVARDI THERAPEUTICS INC | 140755307 | COM | 65,000 | $2,533,050 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 396,396 | $2,445,763 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 301,746 | $2,127,309 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 68,636 | $2,064,571 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 200,000 | $1,738,000 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 252,211 | $1,369,506 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 405,953 | $1,238,157 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155102 | COM CL A | 602,192 | $1,162,231 | dollars as filed | |
| 908 DEVICES INC COM | 65443P102 | Stock | 100,368 | $879,224 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 500,662 | $811,072 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 100,000 | $573,000 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 280,822 | $539,178 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 154,832 | $354,565 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 202,978 | $263,871 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-003321 | this filing | 2025-11-14 | acceptance time not in the bulk data set |